EryDel Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
26
- Latest Deal Type
-
M&A
- Investors
-
1
EryDel General Information
Description
Developer of a non-invasive medical device and therapies designed to facilitate blood processing at the point of care. The company automates the process by handling the blood, drug, and processing systems, and its therapy is based on the unique properties of the erythrocytes to be reversibly opened under hypotonic conditions without losing their functionalities, enabling healthcare professionals to efficiently treat other rare diseases.
Contact Information
Website
www.erydel.comCorporate Office
- Via A. Meucci, 3
- Bresso
- 20091 Milan(Lombardia)
- Italy
Corporate Office
- Via A. Meucci, 3
- Bresso
- 20091 Milan(Lombardia)
- Italy
EryDel Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 08-Sep-2026 | Completed | Generating Revenue | |||
| 6. Merger/Acquisition | 20-Oct-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 24-Apr-2018 | Completed | Generating Revenue | |||
| 4. Grant | 07-Jan-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 11-May-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 03-Sep-2008 | $3.7M | $3.7M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2007 | Completed | Startup |
EryDel Comparisons
Industry
Financing
Details
EryDel Competitors (9)
One of EryDel’s 9 competitors is Baxter International, a Corporation company based in Deerfield, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Baxter International | Corporation | Deerfield, IL | ||||
| Flowonix | Formerly VC-backed | Hackettstown, NJ | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Spark Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Recombinetics | Venture Capital-Backed | New Brighton, MN |
EryDel Patents
EryDel Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3219808-A1 | Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine | Pending | 27-May-2021 | ||
| WO-2022248975-A1 | Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine | Inactive | 27-May-2021 | ||
| CA-2974181-A1 | Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment | Active | 19-Jan-2015 | ||
| CA-2974181-C | Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment | Active | 19-Jan-2015 | ||
| EP-3247805-A1 | Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment | Active | 19-Jan-2015 | C12Q1/6883 |
EryDel Signals
EryDel Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Focus Gestioni | Venture Capital | Minority | ||
| Genextra | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| IRulya Therapeutics | Corporation | Majority | ||
| Innogest Capital | Venture Capital | Minority |
EryDel FAQs
-
When was EryDel founded?
EryDel was founded in 2007.
-
Where is EryDel headquartered?
EryDel is headquartered in Milan, Italy.
-
What is the size of EryDel?
EryDel has 26 total employees.
-
What industry is EryDel in?
EryDel’s primary industry is Drug Delivery.
-
Is EryDel a private or public company?
EryDel is a Private company.
-
What is EryDel’s current revenue?
The current revenue for EryDel is .
-
How much funding has EryDel raised over time?
EryDel has raised $64.2M.
-
Who are EryDel’s investors?
Focus Gestioni, Genextra, Horizon 2020, IRulya Therapeutics, and Innogest Capital are 5 of 6 investors who have invested in EryDel.
-
Who are EryDel’s competitors?
Baxter International, Flowonix, Alzheon, Spark Therapeutics, and Recombinetics are some of the 9 competitors of EryDel.
-
When was EryDel acquired?
EryDel was acquired on 08-Sep-2026.
-
Who acquired EryDel?
EryDel was acquired by Ayma Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process